The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 5
  • 1
    Aspin, Jennifer Anne Elizabeth
    Country Manager born in December 1979
    Individual (2 offsprings)
    Officer
    2022-05-12 ~ now
    OF - Director → CIF 0
  • 2
    Madsen, Egil Molsted
    Chief Financial Officer born in December 1965
    Individual (2 offsprings)
    Officer
    2024-11-28 ~ now
    OF - Director → CIF 0
  • 3
    Lorenzen, Christoffer Mathies
    Ceo born in December 1975
    Individual (4 offsprings)
    Officer
    2019-08-20 ~ now
    OF - Director → CIF 0
  • 4
    Kubica, Susanne Katrin
    Regional Head Of Finance North Western Europe born in May 1973
    Individual (3 offsprings)
    Officer
    2024-11-28 ~ now
    OF - Director → CIF 0
  • 5
    KARO HEALTHCARE UK LTD - now
    KARO PHARMA UK LTD - 2023-03-31
    Klara Norra Kyrkogata, 33, Stockholm, Sweden
    Active Corporate (5 parents, 4 offsprings)
    Equity (Company account)
    1,384,045 GBP2023-12-31
    Person with significant control
    2019-01-23 ~ now
    PE - Ownership of shares – 75% or more → CIF 0
    PE - Ownership of voting rights - 75% or more → CIF 0
    PE - Right to appoint or remove directors → CIF 0
Ceased 5
  • 1
    Raniga, Jeelan
    Head Of Finance/Business Controller Uk/Ireland born in August 1980
    Individual (2 offsprings)
    Officer
    2021-09-08 ~ 2024-11-22
    OF - Director → CIF 0
  • 2
    Mooi, Danique Soe Loek
    Head Of Finance born in May 1975
    Individual
    Officer
    2020-03-01 ~ 2021-08-31
    OF - Director → CIF 0
  • 3
    Blom, Peter
    Director born in December 1961
    Individual
    Officer
    2019-01-23 ~ 2019-06-30
    OF - Director → CIF 0
  • 4
    Langdon, Hayley Louise Elizabeth
    Country Manager born in July 1974
    Individual (1 offspring)
    Officer
    2020-03-01 ~ 2022-05-11
    OF - Director → CIF 0
  • 5
    Nylen, Lars Magnus
    Chief Of Sales born in March 1974
    Individual
    Officer
    2020-03-01 ~ 2021-08-31
    OF - Director → CIF 0
parent relation
Company in focus

KARO HEALTHCARE UK LTD

Previous name
KARO PHARMA UK LTD - 2023-03-31
Standard Industrial Classification
46460 - Wholesale Of Pharmaceutical Goods
Brief company account
Cost of Sales
-15,004,856 GBP2023-01-01 ~ 2023-12-31
-2,837,193 GBP2022-01-01 ~ 2022-12-31
Administrative Expenses
-22,462,210 GBP2023-01-01 ~ 2023-12-31
-7,324,077 GBP2022-01-01 ~ 2022-12-31
Tax/Tax Credit on Profit or Loss on Ordinary Activities
-290,807 GBP2023-01-01 ~ 2023-12-31
-75,828 GBP2022-01-01 ~ 2022-12-31
Profit/Loss
Retained earnings (accumulated losses)
921,179 GBP2023-01-01 ~ 2023-12-31
330,632 GBP2022-01-01 ~ 2022-12-31
Cash and Cash Equivalents
5,575,541 GBP2023-12-31
1,161,529 GBP2022-12-31
Equity
Called up share capital
1,000 GBP2023-12-31
1,000 GBP2022-12-31
Retained earnings (accumulated losses)
1,383,045 GBP2023-12-31
461,866 GBP2022-12-31
Equity
1,384,045 GBP2023-12-31
462,866 GBP2022-12-31
131,234 GBP2021-12-31
Average Number of Employees
442023-01-01 ~ 2023-12-31
182022-01-01 ~ 2022-12-31
Wages/Salaries
3,425,715 GBP2023-01-01 ~ 2023-12-31
1,536,692 GBP2022-01-01 ~ 2022-12-31
Pension & Other Post-employment Benefit Costs/Other Pension Costs
171,855 GBP2023-01-01 ~ 2023-12-31
79,463 GBP2022-01-01 ~ 2022-12-31
Staff Costs/Employee Benefits Expense
3,985,703 GBP2023-01-01 ~ 2023-12-31
1,794,974 GBP2022-01-01 ~ 2022-12-31
Director Remuneration
274,029 GBP2023-01-01 ~ 2023-12-31
290,063 GBP2022-01-01 ~ 2022-12-31
Profit/Loss on Ordinary Activities Before Tax
1,211,986 GBP2023-01-01 ~ 2023-12-31
406,460 GBP2022-01-01 ~ 2022-12-31
Tax Expense/Credit at Applicable Tax Rate
302,997 GBP2023-01-01 ~ 2023-12-31
77,227 GBP2022-01-01 ~ 2022-12-31
Prepayments
Current
29,839 GBP2023-12-31
2,937 GBP2022-12-31
Bank Borrowings/Overdrafts
Current
8,009,678 GBP2023-12-31
2,042,713 GBP2022-12-31
Trade Creditors/Trade Payables
Amounts falling due within one year
9,491,650 GBP2023-12-31
6,695,940 GBP2022-12-31
Current
1,896,401 GBP2023-12-31
1,148,508 GBP2022-12-31
Accrued Liabilities
Current
5,238,635 GBP2023-12-31
2,035,776 GBP2022-12-31
Related profiles found in government register
  • KARO HEALTHCARE UK LTD
    Info
    KARO PHARMA UK LTD - 2023-03-31
    Registered number 11784588
    The Pearce Building, 4th Floor, West Street, Maidenhead SL6 1RL
    Private Limited Company incorporated on 2019-01-23 (6 years 5 months). The company status is Active.
    The last date of confirmation statement was made at 2025-01-22
    CIF 0
  • KARO HEALTHCARE AB
    S
    Registered number missing
    Klara Norra Kyrkogata, 33, Stockholm, Sweden, 103 24
    Public Limited Company
    CIF 1
  • KARO HEALTHCARE AB
    S
    Registered number 556309-3359
    Klara Norra Kyrkogata, 33, Stockholm, Sweden, 103 24
    Swedish Public Limited Liability Company in Swedish Companies Registration Office, Sweden
    CIF 2
  • KARO HEALTHCARE AB
    S
    Registered number 556309-3359
    Klara Norra Kyrkogata, 33, Stockholm, Sweden, 10324
    Swedish Public Limited Liability Company in Swedish Companies Registration Office, Sweden
    CIF 3
(more)
child relation
Offspring entities and appointments
Active 4
  • 1
    C/o Bdo Llp, 5 Temple Square, Liverpool
    Liquidation Corporate (6 parents)
    Person with significant control
    2022-04-01 ~ now
    CIF 4 - Ownership of shares – 75% or more → OE
    CIF 4 - Ownership of voting rights - 75% or more → OE
    CIF 4 - Right to appoint or remove directors → OE
  • 2
    KARO PHARMA UK LTD - 2023-03-31
    The Pearce Building, 4th Floor, West Street, Maidenhead, England
    Active Corporate (5 parents, 4 offsprings)
    Equity (Company account)
    1,384,045 GBP2023-12-31
    Person with significant control
    2019-01-23 ~ now
    CIF 1 - Ownership of shares – 75% or more → OE
    CIF 1 - Ownership of voting rights - 75% or more → OE
    CIF 1 - Right to appoint or remove directors → OE
  • 3
    4th Floor, The Pearce Building, West Street, Maidenhead, England
    Active Corporate (5 parents)
    Equity (Company account)
    7,523,830 GBP2023-12-31
    Person with significant control
    2022-01-13 ~ now
    CIF 3 - Ownership of shares – 75% or more → OE
    CIF 3 - Ownership of voting rights - 75% or more → OE
    CIF 3 - Right to appoint or remove directors → OE
  • 4
    4th Floor, The Pearce Building, West Street, Maidenhead, England
    Active Corporate (4 parents, 1 offspring)
    Equity (Company account)
    -221,337 GBP2023-12-31
    Person with significant control
    2022-01-13 ~ now
    CIF 2 - Ownership of shares – 75% or more → OE
    CIF 2 - Ownership of voting rights - 75% or more → OE
    CIF 2 - Right to appoint or remove directors → OE

qrcode

Privacy notice

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.